Literature DB >> 1831666

The Zurich Study. XI. Is dysthymia a separate form of depression? Results of the Zurich Cohort Study.

J Angst1, W Wicki.   

Abstract

Dysthymia was assessed in the prospective Zurich Cohort Study of young adults. The 1-year prevalence rate was around 3% if no exclusion criteria were applied. Pure dysthymics without major or recurrent brief depression accounted for about 1%. Most cases of dysthymia met the symptom criteria for major depressive disorder (MDD) and were characterized by a more continuous course. However, evidence presented in this paper suggests that a diagnosis separate from MDD is not warranted. The family history of dysthymic subjects did not differ from major depressives. The smaller group of primary dysthymics, on the other hand, did not differ from controls as regards family history for treated depression. The low prevalence rates, taken together with methodological problems involved in assessing dysthymia and the lack of a distinct course, suggest that dysthymia does not constitute a valid subtype of depression in an age group of 20-30 years of the community. Dysthymia belongs to the wide spectrum of major depressive syndromes and represents only a subgroup characterized by specific course characteristics.

Entities:  

Mesh:

Year:  1991        PMID: 1831666     DOI: 10.1007/bf02279765

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  9 in total

Review 1.  [Dysthymic disorders].

Authors:  T Bronisch
Journal:  Nervenarzt       Date:  1990-03       Impact factor: 1.214

2.  The early--late onset distinction in DSM-III-R dysthymia.

Authors:  D N Klein; E B Taylor; S Dickstein; K Harding
Journal:  J Affect Disord       Date:  1988 Jan-Feb       Impact factor: 4.839

3.  A longitudinal study of an untreated sample of predominantly late onset characterological dysthymia.

Authors:  J P McCullough; M D Kasnetz; J A Braith; K F Carr; J H Cones; J Fielo; M F Martelli
Journal:  J Nerv Ment Dis       Date:  1988-11       Impact factor: 2.254

4.  Primary early-onset dysthymia: comparison with primary nonbipolar nonchronic major depression on demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome.

Authors:  D N Klein; E B Taylor; S Dickstein; K Harding
Journal:  J Abnorm Psychol       Date:  1988-11

5.  Treatment planning. Dysthymic disorder complicated by bouts of major depression.

Authors:  A Frances; C B Voss
Journal:  Hosp Community Psychiatry       Date:  1987-05

6.  Dysthymia in the offspring of parents with primary unipolar affective disorder.

Authors:  D N Klein; D C Clark; L Dansky; E T Margolis
Journal:  J Abnorm Psychol       Date:  1988-08

7.  The Zurich study--a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. I. Problem, methodology.

Authors:  J Angst; A Dobler-Mikola; J Binder
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984

Review 8.  A critical discussion of DSM-III dysthymic disorder.

Authors:  J H Kocsis; A J Frances
Journal:  Am J Psychiatry       Date:  1987-12       Impact factor: 18.112

9.  Recurrent brief depression: a new subtype of affective disorder.

Authors:  J Angst; K Merikangas; P Scheidegger; W Wicki
Journal:  J Affect Disord       Date:  1990-06       Impact factor: 4.839

  9 in total
  3 in total

1.  The Zurich Study. XII. Sex differences in depression. Evidence from longitudinal epidemiological data.

Authors:  C Ernst; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

2.  The validity of the diagnosis of depression in general practice: is using criteria for diagnosis as a routine the answer?

Authors:  E M van Weel-Baumgarten; W J van den Bosch; H J van den Hoogen; F G Zitman
Journal:  Br J Gen Pract       Date:  2000-04       Impact factor: 5.386

Review 3.  Epidemiology of depression.

Authors:  J Angst
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.